The BODE index, a multidimensional grading system, reflects impairment of right ventricle functions in patients with chronic obstructive pulmonary disease: A speckle-tracking study

Respiration

Volumn 88, Issue 3, 2014, Pages 223-233

  Gökdeniz, Tayyar ^a   Kalaycioʇlu, Ezgi ^b   Boyaci, Faruk ^b   Aykan, Ahmet Çaʇri ^b   Gürsoy, Mustafa Ozan ^d   Hatem, Engin ^b   Börekçi, Abdurrezak ^a   Karabag, Yavuz ^a   Altun, Selma ^c  

^a KAFKAS UNIVERSITY   (Turkey)

^b Department of Cardiology ^*  (Turkey)

^c Department of Cardiovascular Surgery   (Turkey)

^d Alsancak Nevvar Salih Isgoren State Hospital   (Turkey)

Author keywords

BODE index; Chronic obstructive pulmonary disease; Right ventricular free wall strain; Two dimensional speckle tracking echocardiography

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS INDEX AIRFLOW OBSTRUCTION DYSPNEA EXERCISE CAPACITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HEART PERFORMANCE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHYSICAL PARAMETERS; PRIORITY JOURNAL; PROGNOSIS; PULMONARY ARTERY; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING; TWO DIMENSIONAL SPECKLE TRACKING ECHOCARDIOGRAPHY; YOUNG ADULT; BODY MASS; CASE CONTROL STUDY; COMPLICATION; DYSPNEA; ECHOCARDIOGRAPHY; ECHOGRAPHY; EXERCISE TOLERANCE; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; CASE-CONTROL STUDIES; DYSPNEA; ECHOCARDIOGRAPHY; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84927959352     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000365222     Document Type: Article

References (36)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J: Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
2. Murray CJ, Lopez AD: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269-1276.
3. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med 1980; 93: 391-398.
4. Gerardi DA, Lovett L, Benoit-Connors ML, Reardon JZ, ZuWallack RL: Variables related to increased mortality following out-patient pulmonary rehabilitation. Eur Respir J 1996; 9: 431-435.
5. van Eeden SF, Sin DD: Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. Respiration 2008; 75: 224-238.
6. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-1012.
7. Ong KC, Earnest A, Lu SJ: A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest 2005; 128: 3810-3816.
8. Cote CG, Dordelly LJ, Celli BR: Impact of COPD exacerbations on patient-centered outcomes. Chest 2007; 131: 696-704.
9. Faganello MM, Tanni SE, Sanchez FF, Pelegrino NR, Lucheta PA, Godoy I: BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease. Am J Med Sci 2010; 339: 10-14.
10. Suissa S: Co-morbidity in COPD: the effects of cardiovascular drug therapies. Respiration 2010; 80: 3-7.
11. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE: Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005; 142: 233-239.
12. Burgess MI, Mogulkoc N, Bright-Thomas RJ, Bishop P, Egan JJ, Ray SG: Comparison of echocardiographic markers of right ventricular function in determining prognosis in chronic pulmonary disease. J Am Soc Echocardiogr 2002; 15: 633-639.
13. Akcay M, Yeter E, Durmaz T, Keles T, Akar Bayram N, Uyar M, Davutoglu V, Yüksel I, Kurt M, Bozkurt E: Treatment of acute chronic obstructive pulmonary disease exacerbation improves right ventricle function. Eur J Echocardiogr 2010; 11: 530-536.
14. van Gestel AJ, Kohler M, Steier J, Teschler S, Russi EW, Teschler H: The effects of controlled breathing during pulmonary rehabilitation in patients with COPD. Respiration 2012; 83: 115-124.
15. Sabit R, Bolton CE, Fraser AG, Edwards JM, Edwards PH, Ionescu AA, Cockcroft JR, Shale DJ: Sub-clinical left and right ventricular dysfunction in patients with COPD. Respir Med 2010; 104: 1171-1178.
16. Jurcut R, Giusca S, La Gerche A, Vasile S, Ginghina C, Voigt JU: The echocardiographic assessment of the right ventricle: what to do in 2010? Eur J Echocardiogr 2010; 11: 81-96.
17. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S: Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis 2007; 50: 927-937.
18. Standardization of Spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152: 1107-1136.
19. Russi EW, Karrer W, Brutsche M, Eich C, Fitting JW, Frey M, Geiser T, Kuhn M, Nicod L, Quadri F, Rochat T, Steurer-Stey C, Stolz D; Swiss Respiratory Society: Diagnosis and management of chronic obstructive pulmonary disease: the Swiss guidelines. Official guidelines of the Swiss Respiratory Society. Respiration 2013; 85: 160-174.
20. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller N: Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23: 685-713, quiz 786-788.
21. Gottdiener JS, Bednarz J, Devereux R, Gardin J, Klein A, Manning WJ, Morehead A, Kitzman D, Oh J, Quinones M, Schiller NB, Stein JH, Weissman NJ: American Society of Echocardiography: recommendations for use of echocardiography in clinical trials; a report from the American Society of Echocardiography. J Am Soc Echocardiogr 2004; 17: 1086-1119.
22. Nussbaumer-Ochsner Y, Rabe KF: Systemic manifestations of COPD. Chest 2011; 139: 165-173.
23. Tayyareci Y, Tayyareci G, Tastan CP, Bayazit P, Nisanci Y: Early diagnosis of right ventricular systolic dysfunction by tissue Dopplerderived isovolumic myocardial acceleration in patients with chronic obstructive pulmonary disease. Echocardiography 2009; 26: 1026-1035.
24. Hardegree EL, Sachdev A, Villarraga HR, Frantz RP, McGoon MD, Kushwaha SS, Hsiao JF, McCully RB, Oh JK, Pellikka PA, Kane GC: Role of serial quantitative assessment of right ventricular function by strain in pulmonary arterial hypertension. Am J Cardiol 2013; 111: 143-148.
25. Fukuda Y, Tanaka H, Sugiyama D, Ryo K, Onishi T, Fukuya H, Nogami M, Ohno Y, Emoto N, Kawai H, Hirata K: Utility of right ventricular free wall speckle-tracking strain for evaluation of right ventricular performance in patients with pulmonary hypertension. J Am Soc Echocardiogr 2011; 24: 1101-1108.
26. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF: Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005; 82: 53-59.
27. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR: The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004; 23: 28-33.
28. Cuttica MJ, Shah SJ, Rosenberg SR, Orr R, Beussink L, Dematte JE, Smith LJ, Kalhan R: Right heart structural changes are independently associated with exercise capacity in non-severe COPD. PLoS One 2011; 6:e29069.
29. Schoos MM, Dalsgaard M, Kjærgaard J, Moesby D, Jensen SG, Steffensen I, Iversen KK: Echocardiographic predictors of exercise capacity and mortality in chronic obstructive pulmonary disease. BMC Cardiovasc Disord 2013; 13: 84.
30. Jackman RW, Kandarian SC: The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physio 2004; 287:C834-C843.
31. Gan WQ, Man SF, Senthilselvan A, Sin DD: Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59: 574-580.
32. Vitarelli A, Conde Y, Cimino E, Stellato S, D'Orazio S, D'Angeli I, Nguyen BL, Padella V, Caranci F, Petroianni A, D'Antoni L, Terzano C: Assessment of right ventricular function by strain rate imaging in chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 268-275.
33. Donaldson GC, Seemungal TA, Patel IS, Bhowmik A, Wilkinson TM, Hurst JR, Maccallum PK, Wedzicha JA: Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005; 128: 1995-2004.
34. Boussuges A, Pinet C, Molenat F, Burnet H, Ambrosi P, Badier M, Sainty JM, Orehek J: Left atrial and ventricular filling in chronic obstructive pulmonary disease. An echocardiographic and Doppler study. Am J Respir Crit Care Med 2000; 162: 670-675.
35. Watz H, Waschki B, Meyer T, Kretschmar G, Kirsten A, Claussen M, Magnussen H: Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest 2010; 138: 32-38.
36. Giusca S, Dambrauskaite V, Scheurwegs C, D'hooge J, Claus P, Herbots L, Magro M, Rademakers F, Meyns B, Delcroix M, Voigt JU: Deformation imaging describes right ventricular function better than longitudinal displacement of the tricuspid ring. Heart 2010; 96: 281-288.